Literature DB >> 1930209

Inhibition of microtubule assembly is a possible mechanism of action of mitoxantrone.

C K Ho1, S L Law, H Chiang, M L Hsu, C C Wang, S Y Wang.   

Abstract

We have found that mitoxantrone can inhibit the polymerization of brain tubulin in a dose dependent manner. MXT had relatively high affinity for tubulin but had no appreciable effect on tubulin associated guanosine-triphosphatase (GTPase) activity nor could it compete with vinblastine (VB) and colchicine (Col) for tubulin binding sites. Furthermore, MXT (0.1-10 microM) is antiproliferative to cold-treated (0 degree C) epithelial cells after only brief exposure (30 min). These results indicated that MXT is a microtubule inhibitory agent and can exert its anticellular effect through modulation of microtubule assembly.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1930209     DOI: 10.1016/s0006-291x(05)81263-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Mitoxantrone. A review of its pharmacology and clinical efficacy in the management of hormone-resistant advanced prostate cancer.

Authors:  L R Wiseman; C M Spencer
Journal:  Drugs Aging       Date:  1997-06       Impact factor: 3.923

2.  Mitoxantrone suppresses vascular smooth muscle cell (VSMC) proliferation and balloon injury-induced neointima formation: An in vitro and in vivo study.

Authors:  Yuan Teng; Ziyi Wang; Wen Li; Jianxing Yu; Zhen Shan; Chun Liang; Shenming Wang
Journal:  Bosn J Basic Med Sci       Date:  2017-11-20       Impact factor: 3.363

3.  Localization and molecular interactions of mitoxantrone within living K562 cells as probed by confocal spectral imaging analysis.

Authors:  A Feofanov; S Sharonov; I Kudelina; F Fleury; I Nabiev
Journal:  Biophys J       Date:  1997-12       Impact factor: 4.033

4.  Quantitative confocal spectral imaging analysis of mitoxantrone within living K562 cells: intracellular accumulation and distribution of monomers, aggregates, naphtoquinoxaline metabolite, and drug-target complexes.

Authors:  A Feofanov; S Sharonov; F Fleury; I Kudelina; I Nabiev
Journal:  Biophys J       Date:  1997-12       Impact factor: 4.033

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.